how long before surgery should i stop taking glp 1 Health Rounds: No need to GLP-1 drugs for most patients Ozempic and Surgery: When to

Retatrutide and newer agents Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously

Tachyphylaxis is contingent upon a full 24-hour exposure, as evidenced by a study in which rats treated with liraglutide (with half-life of 11 15 hours) twice daily for 14 days had markedly diminished gastric emptying while those treated with exenatide (with half-life of 2 3 hours) twice daily over the same period still displayed a profound reduction in gastric emptying, although both compounds had similar effects on body weight reduction (158)

Rigorous adjustment for baseline covariates, including comorbidities and prior medication use, strengthens the internal validity of the findings

It is not about willpower

REFERENCES British Menopause Society incretin therapies and HRT NICE tirzepatide guidance NHS England tirzepatide guidance MHRA GLP1 safety guidance Mayo Clinic report on hormone therapy and tirzepatide findings NICE tirzepatide guidance NHS England tirzepatide guidance MHRA GLP1 safety guidance Mayo Clinic report on hormone therapy and tirzepatide findings

Safety Considerations and Side Effects Red flags: sudden mood shifts, uncontrolled hypertension, or seizure history warrant immediate medical follow-up